These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 12923563)
21. Comparison of transgene expression mediated by several Fiber-modified adenovirus vectors in trophoblast cells. Koizumi N; Kondoh M; Mizuguchi H; Nakanishi T; Masuyama A; Ida F; Fujii M; Hayakawa T; Nakashima E; Tanaka K; Watanabe Y Placenta; 2005 Nov; 26(10):729-34. PubMed ID: 16226122 [TBL] [Abstract][Full Text] [Related]
22. Differential role of alpha(v)beta(3) and alpha(v)beta(5) integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses. Majhen D; Nemet J; Richardson J; Gabrilovac J; Hajsig M; Osmak M; Eloit M; Ambriović-Ristov A Virus Res; 2009 Jan; 139(1):64-73. PubMed ID: 19013487 [TBL] [Abstract][Full Text] [Related]
23. Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery. Li E; Brown SL; Von Seggern DJ; Brown GB; Nemerow GR Gene Ther; 2000 Sep; 7(18):1593-9. PubMed ID: 11021598 [TBL] [Abstract][Full Text] [Related]
24. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors. Nakamura T; Sato K; Hamada H Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485 [TBL] [Abstract][Full Text] [Related]
26. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob. Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861 [TBL] [Abstract][Full Text] [Related]
27. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Nicklin SA; Von Seggern DJ; Work LM; Pek DC; Dominiczak AF; Nemerow GR; Baker AH Mol Ther; 2001 Dec; 4(6):534-42. PubMed ID: 11735337 [TBL] [Abstract][Full Text] [Related]
28. Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo. Seki T; Dmitriev I; Suzuki K; Kashentseva E; Takayama K; Rots M; Uil T; Wu H; Wang M; Curiel DT Gene Ther; 2002 Aug; 9(16):1101-8. PubMed ID: 12140738 [TBL] [Abstract][Full Text] [Related]
29. Efficient transduction of murine B lymphocytes and B lymphoma lines by modified adenoviral vectors: enhancement via targeting to FcR and heparan-containing proteins. Li L; Wickham TJ; Keegan AD Gene Ther; 2001 Jun; 8(12):938-45. PubMed ID: 11426334 [TBL] [Abstract][Full Text] [Related]
30. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon. Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548 [TBL] [Abstract][Full Text] [Related]
31. Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells. Lyle C; McCormick F Virol J; 2010 Jul; 7():148. PubMed ID: 20615244 [TBL] [Abstract][Full Text] [Related]
32. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531 [TBL] [Abstract][Full Text] [Related]
33. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD'). Taki M; Kagawa S; Nishizaki M; Mizuguchi H; Hayakawa T; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T Oncogene; 2005 Apr; 24(19):3130-40. PubMed ID: 15735729 [TBL] [Abstract][Full Text] [Related]
34. Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression. You Z; Fischer DC; Tong X; Hasenburg A; Aguilar-Cordova E; Kieback DG Cancer Gene Ther; 2001 Mar; 8(3):168-75. PubMed ID: 11332987 [TBL] [Abstract][Full Text] [Related]
35. Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas. Zeimet AG; Müller-Holzner E; Schuler A; Hartung G; Berger J; Hermann M; Widschwendter M; Bergelson JM; Marth C Gene Ther; 2002 Aug; 9(16):1093-100. PubMed ID: 12140737 [TBL] [Abstract][Full Text] [Related]
36. Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses. Bonsted A; Engesaeter BØ; Høgset A; Maelandsmo GM; Prasmickaite L; Kaalhus O; Berg K Gene Ther; 2004 Jan; 11(2):152-60. PubMed ID: 14712299 [TBL] [Abstract][Full Text] [Related]
37. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity. Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976 [TBL] [Abstract][Full Text] [Related]
38. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569 [TBL] [Abstract][Full Text] [Related]
39. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. Cripe TP; Dunphy EJ; Holub AD; Saini A; Vasi NH; Mahller YY; Collins MH; Snyder JD; Krasnykh V; Curiel DT; Wickham TJ; DeGregori J; Bergelson JM; Currier MA Cancer Res; 2001 Apr; 61(7):2953-60. PubMed ID: 11306473 [TBL] [Abstract][Full Text] [Related]
40. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors. Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]